ClinicalTrials.gov
ClinicalTrials.gov Menu

CrescNet - Growth Monitoring Network (CrescNet)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03072537
Recruitment Status : Recruiting
First Posted : March 7, 2017
Last Update Posted : July 12, 2018
Sponsor:
Information provided by (Responsible Party):
Antje Koerner, Prof. Dr. med., University of Leipzig

Brief Summary:
CrescNet is a network of primary care physicians and pediatricians (n=219) and endocrinological treatment centers (n=33), established in Leipzig in 1998, whose aim is to improve the early detection of growth disorders. Secondary to this clinical aim, epidemiological analyses, for example on secular trends of growth data of children, are performed.

Condition or disease
Obesity Child Development Growth Disorders

Detailed Description:

Pediatricians participating in CrescNet provide pseudononymized data on patients' height, weight, and head circumferences to the CrescNet registry. Growth data are evaluated by automatized filter algorithms and by a pediatric endocrinologist. CrescNet does not have access to patients or personal patient data. Each participating pediatrician receives a quarterly screening report with recommendations for the work-up of children with abnormal growth or abnormal development of weight or body mass index.

The data registry is used for scientific purposes.The collection of data from healthy children allows the generation of evidence based statements about prevalence rates of growth disorders and also about the rates in disorders of weight development. For this, data are provided completely anonymized without allowing conclusions on personal patient data.


Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000000 participants
Observational Model: Other
Time Perspective: Prospective
Target Follow-Up Duration: 18 Years
Official Title: CrescNet - Computer-guided, Population-based Surveillance System for Growth Disorders
Actual Study Start Date : January 1, 1998
Estimated Primary Completion Date : January 1, 2028
Estimated Study Completion Date : January 1, 2028

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Growth Disorders




Primary Outcome Measures :
  1. growth disorders [ Time Frame: 18 years ]
    Early detection of growth disorders in childhood and adolescent development. For this, not only absolute data but also growth velocity data are evaluated.

  2. obesity [ Time Frame: 18 years ]
    detection of critical age periods for the development of obesity. For this, not only absolute data but also growth velocity data are evaluated.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
461,354 boys with 2,350,494 visits und 433,539 girls with 2,216,578 visits from screening and/or consulting visits at 1 of the 252 participating German pediatricians.
Criteria

Inclusion Criteria: Population based sample with inclusion of any patient seen by primary care or institutional physician/pediatrician, regardless of the objective for the visit (well child visits, acute visits or special requests)

Exclusion Criteria: none


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03072537


Contacts
Contact: Roland W Pfäffle, MD roland.pfaeffle@medizin.uni-leipzig.de
Contact: Ruth Gausche gausche@crescnet.org

Locations
Germany
CrescNet - University of Leipzig Recruiting
Leipzig, Saxony, Germany, 04103
Contact: Roland W Pfäffle, MD       roland.pfaeffle@medizin.uni-leipzig.de   
Contact: Ruth Gausche       gausche@crescnet.org   
Sponsors and Collaborators
University of Leipzig
Investigators
Principal Investigator: Roland W Pfäffle, MD University of Leipzig

Additional Information:
Publications of Results:

Other Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Antje Koerner, Prof. Dr. med., Prof. Dr. med. Antje Körner, University of Leipzig
ClinicalTrials.gov Identifier: NCT03072537     History of Changes
Other Study ID Numbers: CrescNet
First Posted: March 7, 2017    Key Record Dates
Last Update Posted: July 12, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Antje Koerner, Prof. Dr. med., University of Leipzig:
growth
BMI
obesity
childhood
adolescence
development

Additional relevant MeSH terms:
Growth Disorders
Pathologic Processes